Mayo Clinic Comprehensive Cancer Center

Personalized #CancerTreatment + leading-edge #CancerResearch and #ClinicalTrials = unparalleled #CancerCare.

[Mayo Clinic @MayoClinic]

Testicular cancer isn't common — about 9,800 men are diagnosed each year and 1 in 250 may be diagnosed in their lifetime — but it most commonly affects men between the ages of 15 and 45. It's not something to worry about; however, it is something to be aware of.

Learn more: https://t.co/oGgbIL4iRU

[Mayo Clinic @MayoClinic]

Mitesh Borad, M.D., an oncologist at Mayo Clinic in Arizona, was part of the research for a new drug proven to give pancreatic cancer patients more time.

He speaks on pancreatic cancer, risk factors and what’s on the horizon for treatment and research: https://t.co/ZTrGIzUs0x

[Mayo Clinic Comprehensive Cancer Center @MayoCancerCare]

Researchers have uncovered a previously hidden step in how the immune system prepares to fight cancer, a discovery that could help scientists develop more effective and longer-lasting cancer immunotherapies, published in @NatureComms.
https://t.co/FyF6uB6ms7

[Mayo Clinic Comprehensive Cancer Center @MayoCancerCare]

Our scientists have revealed the molecular structures of PKCβ, a key protein linked to cancer and neurological diseases, providing the first details of how it works and how the breast cancer drug endoxifen targets this protein, published in @NatureComms. https://t.co/eYos1Vnqay

[Mayo Clinic Comprehensive Cancer Center @MayoCancerCare]

Mayo Clinic thoracic surgeons are using a single-port robotic system for surgeries. This minimally invasive approach enables them to operate with enhanced precision and advances lung cancer care, allowing patients to go home the next day. Learn more:
https://t.co/RvsQD0NXEV.

[Mayo Clinic @MayoClinic]

At Mayo Clinic, neuroscientists are seeking to understand — and ultimately restore — brain function through advanced computational tools, neuromodulation technologies and multidisciplinary collaboration.

These new efforts are led by Gelareh Zadeh, M.D., Ph.D., a neurosurgeon and scientist. Dr. Zadeh specializes in neuro-oncology and has clinical expertise in treating brain tumors such as gliomas and meningiomas.

Learn more: https://t.co/PEkEtrIxgW

[Mayo Clinic Comprehensive Cancer Center @MayoCancerCare]

Our experts understand cancer and have the deep experience needed to treat your precise form of cancer. They also take the time to understand your needs so they can pinpoint the most effective treatments based on your preferences and goals.

Learn more. https://t.co/QryTFRBLPy

[Mayo Clinic Department of Surgery @MayoClinicSurg]

In a recent episode of the @MayoClinic Health Matters podcast, liver and pancreas surgeon Dr. Susanne Warner discusses the warning signs of #LiverCancer, who is most at risk, how liver disease develops & how to protect liver health. Listen to the episode: https://t.co/wAsEMcT2l5

[Mayo Clinic Comprehensive Cancer Center @MayoCancerCare]

Building a supportive community is an important part of our culture, as well as education, awareness and self-care. Plus, @MayoClinic has one of the largest, most experienced multispecialty neurosurgery practices in the U.S. Learn more: https://t.co/s7bTFHE3zb

[Shreya Gandhi @shreya_gandhi2]

Great weather, great company, great cause

Members of #TeamGlioBusters @MayoClinicNeuro @MayoCancerCare came together for a lunchtime walk supporting glioblastoma research & awareness

Proud to walk in support of patients, families, and continued research efforts @gelarehzadeh

[Mayo Clinic Comprehensive Cancer Center @MayoCancerCare]

When Christopher learned he had a treatable but not curable rare blood cancer, he shares, "I sort of came to terms with the idea of: 'You've got a second chance at life.'" His care team provided treatment that focused on what mattered most to him.
https://t.co/M5574YLFhr

[Mayo Clinic @MayoClinic]

Cholangiocarcinoma is a type of cancer that forms in the slender tubes (bile ducts) that carry the digestive fluid bile. It is often diagnosed when it's advanced, making successful treatment difficult to achieve.

In this video, Dr. Rory Smoot, a Mayo Clinic surgical oncologist, explains treatment options.

Learn more: https://t.co/wqfyuA7qku

[Talha Badar @TalhaBadarMD]

Mayo Clinic Comprehensive Cancer Center @ #EHA2026 @MayoCancerCare

#Survival_after_Venetoclax_failure

Dr. Mahnoor Fatima and Dr. Naseema Gangat: One of the largest real-world analyses to date examined 356 newly diagnosed AML patients who failed frontline HMA+venetoclax across the Mayo Clinic enterprise.

1. Outcomes after HMA+VEN failure remain poor, with median survival measured in months ( 4 mo) highlighting a major unmet need in AML.

2. Independent adverse prognostic factors included peripheral blasts ≥20% and complex/monosomal karyotype, while wild-type IDH1 and allogeneic transplant after failure were associated with improved survival.

3. Among salvage approaches, no specific regimen demonstrated a clear survival advantage, emphasizing the need for novel therapeutic strategies and clinical trial enrollment after HMA+VEN failure.

A great example of how Mayo Clinic’s integrated enterprise-wide data can answer clinically relevant questions in difficult-to-treat AML populations.

#AML #Venetoclax #leusm #Leukemia #EHA2026 #RealWorldEvidence

[Aref Al-Kali @AlkaliDr]

@MayoCancerCare experience in sweet syndrome and #AML by @AntoineNSaliba #eha2026

[Aref Al-Kali @AlkaliDr]

Busy poster session with many of @MayoCancerCare staff presenting today. Proud of you 👏 ♥️

@MayoCancerCare #eha2026

@MorieGertz @kimball_md #Kapoor

[Mayo Clinic Comprehensive Cancer Center @MayoCancerCare]

One of the most detailed maps to date of meningioma — the most common brain tumor in adults — reveals how the tumor's surrounding environment helps drive disease behavior and patient outcomes. The study, led by @gelarehzadeh, published in @NatureGenet. https://t.co/nT5KlgXQYx

[Mayo Clinic @MayoClinic]

Pancreatic cancer rarely is found at its early stages when the chance of curing it is greatest. This is because it often doesn't cause symptoms until after it has spread to other organs.

Dr. Mark Truty, a Mayo Clinic surgical oncologist, explains how pancreatic cancer is often treated.

Learn more about pancreatic cancer symptoms, diagnosis and treatment: https://t.co/FfurrPEmtJ

[Aadel Chaudhuri, MD PhD @aadel_chaudhuri]

Excited to share our latest paper out today in @CCR_AACR, led by first authors Ayesha Hashmi, Jessica Linford and Pradeep Chauhan (@pradeep198212) in my lab @MayoRadOnc @MayoCancerCare @MayoClinic.

https://t.co/BARU2qs7Kj

[Mayo Clinic @MayoClinic]

As Microsoft Build concludes, Mayo Clinic's collaboration with @Microsoft marks an important step in the ongoing development of AI tools designed specifically for healthcare.

During the conference, Dr. @GFarrugiaMD, president and CEO of Mayo Clinic, discussed the collaboration, which combines Mayo Clinic's clinical expertise and healthcare insights with Microsoft's AI and engineering capabilities.

Together, we are working to develop a frontier AI model designed to support healthcare applications, including earlier diagnosis, more personalized treatment decisions, and improved experiences for patients and care teams. AI can help inform clinical decision-making while healthcare professionals remain at the center of patient care.

Unlike general-purpose AI systems, healthcare requires clinical context, governance, and real-world validation. The collaboration reflects Mayo Clinic's continued focus on responsible AI development, patient trust, and the safe use of clinical data.

Learn more: https://t.co/ezQFj3meWi

#MicrosoftBuild #HealthcareAI #Innovation

[Mayo Clinic Comprehensive Cancer Center @MayoCancerCare]

Early results from a first-in-human clinical trial led by @ZakhariaYousef show that the investigational drug darlifarnib in combination with the targeted therapy cabozantinib may help overcome treatment resistance in advanced kidney cancer. https://t.co/VVpO6kx42f

[Mayo Clinic Department of Surgery @MayoClinicSurg]

For people diagnosed with #EsophagealCancer, surgery remains an important part of treatment. Determining if and when surgery should occur depends on the stage of the cancer, as well as other individual factors. Read more: https://t.co/0kdE0d0XkB